List of bibliographic references indexed by Antinéoplasiques
Number of relevant bibliographic references: 10.
| Ident. | Authors (with country if any) | Title |
|---|
| 000249 (2020) |
Elie Rassy [Liban] ; Rita-Maria Khoury-Abboud [Liban] ; Nathalie Ibrahim [Liban] ; Clarisse Kattan [Liban] ; Tarek Assi [Liban] ; Joseph Kattan [Liban] | What the oncologist needs to know about COVID-19 infection in cancer patients. |
| 000922 (2020) |
Florian Lemaitre [France] ; Caroline Solas [France] ; Matthieu Grégoire [France] ; Laurence Lagarce [France] ; Laure Elens [Belgique] ; Elisabeth Polard [France] ; Béatrice Saint-Salvi [France] ; Agnès Sommet [France] ; Michel Tod [France] ; Chantal Barin-Le Guellec [France] | Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments. |
| 000A14 (2020) |
Vincent Lavoué [France] ; Cherif Akladios [France] ; Laurence Gladieff [France] ; Jean-Marc Classe [France] ; Fabrice Lécuru [France] ; Pierre Collinet [France] | Onco-gynecologic surgery in the COVID-19 era: Risks and precautions-A position paper from FRANCOGYN, SCGP, SFCO, and SFOG. |
| 000D44 (2020) |
Stefanie Aeppli [Suisse] ; Eric Innocents Eboulet [Suisse] ; Tim Eisen [Royaume-Uni] ; Bernard Escudier [France] ; Stefanie Fischer [Suisse] ; James Larkin [Royaume-Uni] ; Viktor Gruenwald [Allemagne] ; David Mcdermott [États-Unis] ; Jan Oldenburg [Norvège] ; Aurelius Omlin [Suisse] ; Camillo Porta [Italie] ; Brian Rini [États-Unis] ; Manuela Schmidinger [Autriche] ; Cora Sternberg [États-Unis] ; Christian Rothermundt [Suisse] | Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma. |
| 001233 (2020) |
Sophie Postel-Vinay [France] ; Christophe Massard [France] ; Jean-Charles Soria [France] | Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management? |
| 001388 (2020) |
Luana Calabr [Italie] ; Solange Peters [Suisse] ; Jean-Charles Soria [France] ; Anna Maria Di Giacomo [Italie] ; Fabrice Barlesi [France] ; Alessia Covre [Italie] ; Maresa Altomonte [Italie] ; Virginia Vegni [Italie] ; Cesare Gridelli [Italie] ; Martin Reck [Allemagne] ; Naiyer Rizvi [États-Unis] ; Michele Maio [Italie] | Challenges in lung cancer therapy during the COVID-19 pandemic. |
| 001406 (2020) |
Florian Slimano [France] ; Amandine Baudouin [France] ; Jérémie Zerbit [France] ; Anne Toulemonde-Deldicque [France] ; Audrey Thomas-Schoemann [France] ; Régine Chevrier [France] ; Mikaël Daouphars [France] ; Isabelle Madelaine [France] ; Bertrand Pourroy [France] ; Jean-François Tournamille [France] ; Alain Astier [France] ; Florence Ranchon [France] ; Jean-Louis Cazin [France] ; Christophe Bardin [France] ; Catherine Rioufol [France] | Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). |
| 001532 (2020) |
Frederic Di Fiore [France] ; Olivier Bouché [France] ; Come Lepage [France] ; David Sefrioui [France] ; Alice Gangloff [France] ; Lilian Schwarz [France] ; Jean Jacques Tuech [France] ; Thomas Aparicio [France] ; Thierry Lecomte [France] ; Camille Boulagnon-Rombi [France] ; Astrid Lièvre [France] ; Sylvain Manfredi [France] ; Jean Marc Phelip [France] ; Pierre Michel [France] | COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). |
| 001599 (2020) |
Giuseppe Di Lorenzo [Italie] ; Rossella Di Trolio [Italie] ; Zisis Kozlakidis [France] ; Giuseppina Busto [Italie] ; Concetta Ingenito [Italie] ; Luciana Buonerba [Italie] ; Claudia Ferrara [Italie] ; Annamaria Libroia [Italie] ; Gianluca Ragone [Italie] ; Concetta Dello Ioio [Italie] ; Beatrice Savastano [Italie] ; Mario Polverino [Italie] ; Ferdinando De Falco [Italie] ; Simona Iaccarino [Italie] ; Emilio Leo [Italie] | COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature. |
| 001695 (2020) |
Paul Gougis [France] ; Charlotte Fenioux [France] ; Christian Funck-Brentano [France] ; Marianne Veyri [France] ; Joseph Gligorov [France] ; Caroline Solas [France] ; Jean-Philippe Spano [France] | Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use? |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Antinéoplasiques"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i \
-Sk "Antinéoplasiques" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= MeshFr.i
|clé= Antinéoplasiques
}}
| This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021 |  |
